Polymorphisms in repair genes (BRCA1, BRCA2, CHEK2, XRCC1, XPD) can reduce DNA repair efficiency, leading to genomic instability and increased breast cancer risk. This evidence concerns the gene ERCC2 and breast carcinoma.